Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guillem Jorba
Institutions:
Institute for Research in Biomedicine,
Barcelona Institute of Science and Technology
Observed institutions:
Universitat Pompeu Fabra,
Institute for Research in Biomedicine,
Barcelona Institute of Science and Technology,
Anaxomics (Spain)
ORCID:
0000-0001-5209-5353
Observed ORCID:
0000-0001-5209-5353
OpenAlex ID:
A5067456605
Targeting autophagy in disease: established and new strategies
2021
·
Muhammed Kocak
, Saba Ezazi Erdi
, et al.
·
Autophagy
·
244
PDF
In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan
2020
·
Guillem Jorba
, Joaquim Aguirre-Plans
, et al.
·
PLoS ONE
·
53
PDF
Comprehensive detection and characterization of human druggable pockets through binding site descriptors
2024
·
Arnau Comajuncosa-Creus
, Guillem Jorba
, et al.
·
Nature Communications
·
39
PDF
Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate
2021
·
José Ramón Gutiérrez-Casares
, Javier Quintero
, et al.
·
Frontiers in Psychiatry
·
27
PDF
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
2021
·
Enric Carcereny
, Alonso Fernández-Nistal
, et al.
·
Oncotarget
·
25
PDF
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
2023
·
Pablo Coto-Segura
, Cristina Segú-Vergés
, et al.
·
Frontiers in Immunology
·
13
The usage of transcriptomics datasets as sources of Real-World Data for clinical trialling
2022
·
Pedro Matos-Filipe
, Juan Manuel García-Illarramendi
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
Show more works
View as search
Works count:
7
Citation count:
405
H-index:
6
I10-index:
6
Year
Topic
Type